| scholarly article | Q13442814 |
| P50 | author | Heejoon Myung | Q42326418 |
| Minjin Kim | Q87670234 | ||
| P2093 | author name string | Yoon Jung Hwang | |
| Yunyeol Jo | |||
| Hye Won Hong | |||
| Kwangseo Park | |||
| Sung Sik Hong | |||
| P2860 | cites work | SOS response and its regulation on the fluoroquinolone resistance | Q26774868 |
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics | Q28390950 | ||
| Stochastic holin expression can account for lysis time variation in the bacteriophage λ. | Q30577378 | ||
| Phage-Antibiotic Synergy (PAS): beta-lactam and quinolone antibiotics stimulate virulent phage growth | Q33295385 | ||
| The use of antibiotics to improve phage detection and enumeration by the double-layer agar technique | Q33486138 | ||
| Degradation of AIMP1/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-β signaling and increase in surface expression of gp96. | Q33590116 | ||
| Genetic analysis of the T4 holin: timing and topology | Q33938601 | ||
| Lysis and lysis inhibition in bacteriophage T4: rV mutations reside in the holin t gene | Q33992595 | ||
| Holin triggering in real time | Q34156732 | ||
| Protein determinants of phage T4 lysis inhibition. | Q34258546 | ||
| Genetic dissection of T4 lysis. | Q34413903 | ||
| Holins in bacteria, eukaryotes, and archaea: multifunctional xenologues with potential biotechnological and biomedical applications | Q34435161 | ||
| Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. | Q34483463 | ||
| Z ring as executor of bacterial cell division | Q34567012 | ||
| The holin of bacteriophage lambda forms rings with large diameter | Q34826283 | ||
| Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strain | Q34933801 | ||
| Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity. | Q34933915 | ||
| P1 Ref Endonuclease: A Molecular Mechanism for Phage-Enhanced Antibiotic Lethality | Q35893892 | ||
| Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms | Q36246210 | ||
| Simple method for plating Escherichia coli bacteriophages forming very small plaques or no plaques under standard conditions | Q36844815 | ||
| Visualization of pinholin lesions in vivo. | Q36895531 | ||
| Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance | Q38119830 | ||
| Viral host-adaptation: insights from evolution experiments with phages | Q38124540 | ||
| Phage lysis: three steps, three choices, one outcome | Q38192505 | ||
| Microbiological effects of sublethal levels of antibiotics. | Q38214805 | ||
| SOS, the formidable strategy of bacteria against aggressions. | Q38219786 | ||
| Quinolone uptake by bacteria and bacterial killing | Q38286338 | ||
| How much territory can a single E. coli cell control? | Q38466759 | ||
| Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa. | Q39549049 | ||
| Regulated CRISPR Modules Exploit a Dual Defense Strategy of Restriction and Abortive Infection in a Model of Prokaryote-Phage Coevolution | Q40348396 | ||
| The Last r Locus Unveiled: T4 RIII Is a Cytoplasmic Antiholin. | Q40624240 | ||
| Functional characterization of a novel lytic phage EcSw isolated from Sus scrofa domesticus and its potential for phage therapy | Q41387963 | ||
| Evolved Populations of Shigella flexneri Phage Sf6 Acquire Large Deletions, Altered Genomic Architecture, and Faster Life Cycles | Q42047038 | ||
| A nonisotopic assay method for hepatitis C virus NS5B polymerase | Q43036582 | ||
| Regulation of transcription of cell division genes in the Escherichia coli dcw cluster | Q48007350 | ||
| Does Treatment Order Matter? Investigating the Ability of Bacteriophage to Augment Antibiotic Activity against Staphylococcus aureus Biofilms. | Q49829450 | ||
| A sensitive and simple plaque formation method for the Stx2 phage of Escherichia coli O157:H7, which does not form plaques in the standard plating procedure. | Q53197495 | ||
| Piperacillin and ceftazidime produce the strongest synergistic phage-antibiotic effect in Pseudomonas aeruginosa. | Q54254128 | ||
| Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. | Q54338053 | ||
| Enumeration of bacteriophages by double agar overlay plaque assay | Q82886385 | ||
| Purification of Bacteriophage λ Particles by Centrifugation through a Glycerol Step Gradient | Q83834070 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P577 | publication date | 2018-10-30 | |
| P1433 | published in | Applied and Environmental Microbiology | Q4781593 |
| P1476 | title | Phage-Antibiotic Synergy via Delayed Lysis. | |
| P478 | volume | 84 |
| Q90663241 | Bacteriophage Therapy: Developments and Directions |
| Q90424133 | Lying in Wait: Modeling the Control of Bacterial Infections via Antibiotic-Induced Proviruses |
| Q98177604 | Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics? |
Search more.